61 – 70 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Determination of age-specific and sex-specific familial risks for the different manifestations of venous thromboembolism: A nationwide family study in Sweden.
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
(
- Contribution to journal › Article
- 2010
-
Mark
The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype
(
- Contribution to journal › Letter
-
Mark
Safety and tolerability of an immediate-release formulation of theoral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
(
- Contribution to journal › Article
- 2009
-
Mark
Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia
(
- Contribution to journal › Letter
-
Mark
The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor
(
- Contribution to journal › Article
-
Mark
Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation
(
- Contribution to journal › Article
-
Mark
Platelets interact with bacterial pathogens.
(
- Contribution to journal › Article
- 2008
-
Mark
Surgical evaluation of a recombinant factorVIII prepared using a plasma/albumin-free method: Efficacy and safety of Advate in previously treated patients
(
- Contribution to journal › Article
-
Mark
Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes
(
- Contribution to journal › Article